Yuxin Liang
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
Papers in
-
- RNA Research and Splicing 5
- RNA modifications and cancer 5
- CRISPR and Genetic Engineering 5
- Advanced biosensing and bioanalysis techniques 4
- Extracellular vesicles in disease 4
- Immunology 12
- Immune cells in cancer 5
- Co-authors
- Zora Modrušan (4 shared papers)Casey C. Case (5 shared papers)Edward J. Rebar (5 shared papers)Bingliang Chen (4 shared papers)Alan P. Wolffe (4 shared papers)Claudia X. Dominguez (1 shared paper)Jeffrey Hung (1 shared paper)Oded Foreman (1 shared paper)
- Journals
- Frontiers in Immunology (5 papers)Journal of Biological Chemistry (4 papers)BMC Cancer (3 papers)Journal of Religion and Health (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yuxin Liang
73 papers receiving 2.1k citations
Yuxin Liang's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 525
- Cancer Research 255
- Molecular Biology 1.1k
- Immunology 267
- Aging 19
Countries citing papers authored by Yuxin Liang
This map shows the geographic impact of Yuxin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxin Liang more than expected).
Fields of papers citing papers by Yuxin Liang
This network shows the impact of papers produced by Yuxin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxin Liang. The network helps show where Yuxin Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuxin Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy Hit paper breakdown → | 2019 | 551 |
| 2 | 2002 | 212 | |
| 3 | 2001 | 206 | |
| 4 | 2000 | 96 | |
| 5 | 1996 | 91 | |
| 6 | 2009 | 89 | |
| 7 | 2023 | 86 | |
| 8 | 2021 | 45 | |
| 9 | 2023 | 44 | |
| 10 | 2020 | 41 | |
| 11 | 2023 | 40 | |
| 12 | 2023 | 38 | |
| 13 | 2022 | 31 | |
| 14 | 2002 | 30 | |
| 15 | 2002 | 28 | |
| 16 | 2017 | 28 | |
| 17 | 2020 | 26 | |
| 18 | 2023 | 26 | |
| 19 | 2024 | 25 | |
| 20 | 2024 | 25 |
About Yuxin Liang
Yuxin Liang is a scholar working on Molecular Biology, Immunology, Oncology, Biomedical Engineering and Materials Chemistry, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), RNA modifications and cancer (5 papers), Immune cells in cancer (5 papers), CRISPR and Genetic Engineering (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Extracellular vesicles in disease (4 papers). The work is most often cited by research in Oncology (525 citations), Cancer Research (255 citations), Molecular Biology (1.1k citations), Immunology (267 citations) and Aging (19 citations). Yuxin Liang has collaborated with scholars based in China, United States and France. Frequent co-authors include Zora Modrušan, Casey C. Case, Edward J. Rebar, Bingliang Chen, Alan P. Wolffe, Claudia X. Dominguez, Jeffrey Hung, Oded Foreman, Melissa R. Junttila and Christiaan Klijn. Their work appears in journals such as Frontiers in Immunology, Journal of Biological Chemistry, BMC Cancer, Journal of Religion and Health and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.